An analysis of the therapeutic benefits of genotyping in pediatric hematopoietic stem cell transplantation

Future Oncology
Felicity A WrightTracey A O'Brien

Abstract

Hematopoietic stem cell transplantation is a high-risk procedure that is offered, with curative intent, to patients with malignant and nonmalignant disease. The clinical benefits of personalization of therapy by genotyping have been demonstrated by the reduction in transplant related mortality from donor-recipient HLA matching. However, defining the relationship between genotype and transplant conditioning agents is yet to be translated into clinical practice. A number of the therapeutic agents used in stem cell transplant preparative regimens have pharmacokinetic parameters that predict benefit of incorporating pharmacogenomic data into dosing strategies. Busulfan, cyclophosphamide, thio-TEPA and etoposide have well-described drug metabolism pathways, however candidate gene studies have identified there is a gap in the identification of pharmacogenomic data that can be used to improve transplant outcomes. Incorporating pharmacogenomics into pharmacokinetic modeling may demonstrate the therapeutic benefits of genotyping in transplant preparative regimen agents.

References

Nov 9, 2000·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·B S AnderssonW P Vaughan
Mar 31, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kim RobienCornelia M Ulrich
May 28, 2004·Nature·William E Evans, Mary V Relling
Feb 2, 2006·Clinica Chimica Acta; International Journal of Clinical Chemistry·Makiko KusamaTatsuji Iga
Mar 22, 2006·Oncogene·C Rodriguez-Antona, M Ingelman-Sundberg
Jan 20, 2007·Blood·H Joachim Deeg
Jan 24, 2007·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Charles G Mullighan, Peter G Bardy
Jun 1, 2007·Proceedings of the National Academy of Sciences of the United States of America·R Stephanie HuangM Eileen Dolan
Dec 27, 2007·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Imke H BartelinkJaap J Boelens
Apr 19, 2008·Nature·David A WheelerJonathan M Rothberg
Sep 12, 2008·Clinical Pharmacology and Therapeutics·M J BijlB H Ch Stricker
Dec 17, 2008·British Journal of Clinical Pharmacology·Corine EkhartAlwin D R Huitema
Dec 18, 2008·Human Genetics·Wasim K BleibelM Eileen Dolan
Jan 29, 2009·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Jason W ChienJohn A Hansen
Jul 9, 2009·Bone Marrow Transplantation·M AnsariM Krajinovic
Jul 21, 2009·Expert Opinion on Drug Metabolism & Toxicology·Jeannine S McCune, Leona A Holmberg
Dec 8, 2010·Journal of Clinical Pharmacology·Nissa AbbasiJeannine S McCune
Jan 14, 2011·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Charles MullighanJohn DiPersio
Jan 11, 2011·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Sung-Doo KimKyoo-Hyung Lee
Jul 13, 2011·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Weijie CaoHe Huang
Nov 4, 2011·Molecular Diagnosis & Therapy·Min Sun KimHyo Seop Ahn
Feb 4, 2012·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Bernd GruhnDaniel Steinbach
Nov 20, 2012·Expert Opinion on Drug Metabolism & Toxicology·Ariane Galaup, Angelo Paci
Nov 29, 2012·Frontiers in Genetics·Guillermo Gervasini, Jose M Vagace

❮ Previous
Next ❯

Methods Mentioned

BETA
genotyping
PCR
1
MDS

Software Mentioned

HUGO

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.